open access

Vol 15, No 1 (2020)
Review Papers
Get Citation

A fresh perspective on anticoagulant therapy in patients with cancer in the era of NOAC

Agnieszka Bureta, Bartosz Kwiatkowski, Małgorzata Lelonek
Folia Cardiologica 2020;15(1):27-33.

open access

Vol 15, No 1 (2020)
Review Papers

Abstract

Cancer is a condition associated with hypercoagulability requiring anticoagulant therapy. In recent years, oncological patients have been given heparin and vitamin K antagonists. Nowadays, non-vitamin K antagonist oral anticoagulants (NOAC) are becoming increasingly widely used. Based on the current state of knowledge, NOAC drugs can be used in anticoagulant treatment of cancer patients with caution, i.e. after assessing the bleeding risk and a risk-benefit analysis of anticoagulant therapy, as well as of the drug interactions between oncological drugs and the NOAC group.

Abstract

Cancer is a condition associated with hypercoagulability requiring anticoagulant therapy. In recent years, oncological patients have been given heparin and vitamin K antagonists. Nowadays, non-vitamin K antagonist oral anticoagulants (NOAC) are becoming increasingly widely used. Based on the current state of knowledge, NOAC drugs can be used in anticoagulant treatment of cancer patients with caution, i.e. after assessing the bleeding risk and a risk-benefit analysis of anticoagulant therapy, as well as of the drug interactions between oncological drugs and the NOAC group.

Get Citation

Keywords

cancer, anticoagulant treatment, non-vitamin K antagonist oral anticoagulants

About this article
Title

A fresh perspective on anticoagulant therapy in patients with cancer in the era of NOAC

Journal

Folia Cardiologica

Issue

Vol 15, No 1 (2020)

Pages

27-33

Bibliographic record

Folia Cardiologica 2020;15(1):27-33.

Keywords

cancer
anticoagulant treatment
non-vitamin K antagonist oral anticoagulants

Authors

Agnieszka Bureta
Bartosz Kwiatkowski
Małgorzata Lelonek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl